HUP0402036A3 - Vascular stent or graft coated or impregnated with protein tyrosine kinase inhibitors and method of using same - Google Patents
Vascular stent or graft coated or impregnated with protein tyrosine kinase inhibitors and method of using sameInfo
- Publication number
- HUP0402036A3 HUP0402036A3 HU0402036A HUP0402036A HUP0402036A3 HU P0402036 A3 HUP0402036 A3 HU P0402036A3 HU 0402036 A HU0402036 A HU 0402036A HU P0402036 A HUP0402036 A HU P0402036A HU P0402036 A3 HUP0402036 A3 HU P0402036A3
- Authority
- HU
- Hungary
- Prior art keywords
- impregnated
- same
- tyrosine kinase
- kinase inhibitors
- protein tyrosine
- Prior art date
Links
- 239000005483 tyrosine kinase inhibitor Substances 0.000 title 1
- 230000002792 vascular Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34373201P | 2001-10-25 | 2001-10-25 | |
PCT/US2002/034344 WO2003034938A2 (en) | 2001-10-25 | 2002-10-25 | Vascular stent or graft coated or impregnated with protein tyrosine kinase inhibitors and method of using same |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0402036A2 HUP0402036A2 (hu) | 2005-02-28 |
HUP0402036A3 true HUP0402036A3 (en) | 2008-04-28 |
Family
ID=23347387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0402036A HUP0402036A3 (en) | 2001-10-25 | 2002-10-25 | Vascular stent or graft coated or impregnated with protein tyrosine kinase inhibitors and method of using same |
Country Status (18)
Country | Link |
---|---|
US (1) | US20040044405A1 (hu) |
EP (1) | EP1441749A4 (hu) |
JP (1) | JP2006519623A (hu) |
KR (1) | KR20040051618A (hu) |
CN (1) | CN1635858A (hu) |
BR (1) | BR0213497A (hu) |
CA (1) | CA2464093A1 (hu) |
CO (1) | CO5580792A2 (hu) |
EC (1) | ECSP045085A (hu) |
HU (1) | HUP0402036A3 (hu) |
IL (1) | IL161583A0 (hu) |
MX (1) | MXPA04003906A (hu) |
NO (1) | NO20042133L (hu) |
NZ (1) | NZ532593A (hu) |
PL (1) | PL374315A1 (hu) |
RU (1) | RU2004116068A (hu) |
WO (1) | WO2003034938A2 (hu) |
ZA (1) | ZA200403184B (hu) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1509219A1 (en) * | 2002-05-13 | 2005-03-02 | Beth Israel Deaconess Medical Center | Methods and compositions for the treatment of graft failure |
EP2165675B1 (en) | 2002-06-26 | 2018-03-07 | Cook Medical Technologies LLC | Stent-graft fastening |
US20050214343A1 (en) * | 2002-07-18 | 2005-09-29 | Patrice Tremble | Medical devices comprising a protein-tyrosine kinase inhibitor to inhibit restonosis |
EP1635815A4 (en) * | 2003-06-03 | 2009-03-25 | Beth Israel Hospital | METHOD AND COMPOUNDS FOR TREATING TISSUE TESTS |
WO2005095641A1 (en) * | 2004-03-03 | 2005-10-13 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with mitogen-activated protein kinase kinase kinase 11 (map3k11) |
EP1720904A4 (en) | 2004-03-05 | 2007-08-22 | Regenerx Biopharmaceuticals | TREATMENT OR PREVENTION OF EXTRACELLULAR MATRIX FORMATION |
MX2007001155A (es) * | 2004-07-29 | 2007-08-14 | Creabilis Therapeutics Spa | Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1. |
WO2007033152A2 (en) * | 2005-09-12 | 2007-03-22 | Conor Medsystems, Inc. | Composition, system and method for modulating release kinetics in implantable drug delivery devices by modifying drug solubility |
US20070196428A1 (en) * | 2006-02-17 | 2007-08-23 | Thierry Glauser | Nitric oxide generating medical devices |
JP5110559B2 (ja) * | 2006-11-24 | 2012-12-26 | 学校法人近畿大学 | 被覆ステント |
US8217172B2 (en) | 2007-12-07 | 2012-07-10 | Vertex Pharmaceuticals Incorporated | Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo[d]imidazol-2-yl)urea |
EP2285443B1 (en) * | 2008-05-01 | 2016-11-23 | Bayer Intellectual Property GmbH | Catheter balloon drug adherence techniques and methods |
US20110086891A1 (en) | 2009-02-13 | 2011-04-14 | Vertex Pharmaceuticals Incorporated | Solid Forms of 2-(2,4-Difluorophenyl)-6-(1-(2,6-Difluorophenyl)Ureido)Nicotinamide) |
US9265633B2 (en) | 2009-05-20 | 2016-02-23 | 480 Biomedical, Inc. | Drug-eluting medical implants |
US9309347B2 (en) | 2009-05-20 | 2016-04-12 | Biomedical, Inc. | Bioresorbable thermoset polyester/urethane elastomers |
WO2010135433A1 (en) * | 2009-05-20 | 2010-11-25 | Arsenal Medical, Inc. | Medical implant |
US8992601B2 (en) | 2009-05-20 | 2015-03-31 | 480 Biomedical, Inc. | Medical implants |
US20110319987A1 (en) | 2009-05-20 | 2011-12-29 | Arsenal Medical | Medical implant |
US8888840B2 (en) * | 2009-05-20 | 2014-11-18 | Boston Scientific Scimed, Inc. | Drug eluting medical implant |
US8372133B2 (en) * | 2009-10-05 | 2013-02-12 | 480 Biomedical, Inc. | Polymeric implant delivery system |
CA2824516C (en) | 2011-01-14 | 2019-02-26 | Vertex Pharmaceuticals Incorporated | Pyrimidine gyrase and topoisomerase iv inhibitors |
MX341342B (es) | 2011-01-14 | 2016-08-17 | Vertex Pharma | Formas solidas del inhibidor de girasa (r)-1-etil-3-[6-fluoro-5-[2 -(1-hidroxi-1-metil-etil) pirimidin-5-il]-7-(tetrahidrofuran-2-il) -1h-benzimidazol-2-il]urea. |
US9187953B2 (en) | 2011-03-23 | 2015-11-17 | Rytec Corporation | Side column configuration for overhead roll-up door assemblies |
TWI554515B (zh) | 2011-06-20 | 2016-10-21 | 維泰克斯製藥公司 | 旋轉酶(gyrase)及拓樸異構酶抑制劑之磷酸酯 |
WO2013003157A1 (en) | 2011-06-28 | 2013-01-03 | Yale University | Cell-free tissued engineered vascular grafts |
US9018216B2 (en) | 2012-07-18 | 2015-04-28 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof |
RU2675270C2 (ru) | 2013-10-17 | 2018-12-18 | Вертекс Фармасьютикалз Инкорпорейтед | Сокристаллы и содержащие их фармацевтические композиции |
US11541149B2 (en) | 2015-12-11 | 2023-01-03 | Research Institute At Nationwide Children's Hospital | Systems and methods for optimized patient specific tissue engineering vascular grafts |
WO2018102074A1 (en) * | 2016-11-04 | 2018-06-07 | University Of Delaware | Method for protecting skeletonized blood vessels |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4824436A (en) * | 1985-04-09 | 1989-04-25 | Harvey Wolinsky | Method for the prevention of restenosis |
US5171217A (en) * | 1991-02-28 | 1992-12-15 | Indiana University Foundation | Method for delivery of smooth muscle cell inhibitors |
US5521184A (en) * | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
US6306421B1 (en) * | 1992-09-25 | 2001-10-23 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5354774A (en) * | 1992-12-24 | 1994-10-11 | Yale University | Inhibition of smooth muscle cell proliferation by 8-methoxypsoralen photoactivated by visible light |
US5279565A (en) * | 1993-02-03 | 1994-01-18 | Localmed, Inc. | Intravascular treatment apparatus and method |
US5788687A (en) * | 1994-02-01 | 1998-08-04 | Caphco, Inc | Compositions and devices for controlled release of active ingredients |
US5788979A (en) * | 1994-07-22 | 1998-08-04 | Inflow Dynamics Inc. | Biodegradable coating with inhibitory properties for application to biocompatible materials |
US6306165B1 (en) * | 1996-09-13 | 2001-10-23 | Meadox Medicals | ePTFE small caliber vascular grafts with significant patency enhancement via a surface coating which contains covalently bonded heparin |
US6245760B1 (en) * | 1997-05-28 | 2001-06-12 | Aventis Pharmaceuticals Products, Inc | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
CO4940418A1 (es) * | 1997-07-18 | 2000-07-24 | Novartis Ag | Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso |
EP1085880A2 (en) * | 1998-06-11 | 2001-03-28 | Cerus Corporation | Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells |
AU3704101A (en) * | 2000-02-17 | 2001-08-27 | Amgen Inc | Kinase inhibitors |
AU2002235175A1 (en) * | 2000-12-06 | 2002-06-18 | Tularik, Inc. | Lometrexol combination therapy |
US6872715B2 (en) * | 2001-08-06 | 2005-03-29 | Kosan Biosciences, Inc. | Benzoquinone ansamycins |
-
2002
- 2002-10-25 PL PL02374315A patent/PL374315A1/xx not_active Application Discontinuation
- 2002-10-25 RU RU2004116068/14A patent/RU2004116068A/ru not_active Application Discontinuation
- 2002-10-25 NZ NZ532593A patent/NZ532593A/en unknown
- 2002-10-25 EP EP02784295A patent/EP1441749A4/en not_active Withdrawn
- 2002-10-25 KR KR10-2004-7006059A patent/KR20040051618A/ko not_active Application Discontinuation
- 2002-10-25 BR BRPI0213497-7A patent/BR0213497A/pt not_active IP Right Cessation
- 2002-10-25 JP JP2003537510A patent/JP2006519623A/ja active Pending
- 2002-10-25 US US10/280,576 patent/US20040044405A1/en not_active Abandoned
- 2002-10-25 HU HU0402036A patent/HUP0402036A3/hu unknown
- 2002-10-25 MX MXPA04003906A patent/MXPA04003906A/es not_active Application Discontinuation
- 2002-10-25 CA CA002464093A patent/CA2464093A1/en not_active Abandoned
- 2002-10-25 IL IL16158302A patent/IL161583A0/xx unknown
- 2002-10-25 CN CNA028211502A patent/CN1635858A/zh active Pending
- 2002-10-25 WO PCT/US2002/034344 patent/WO2003034938A2/en active Application Filing
-
2004
- 2004-04-23 EC EC2004005085A patent/ECSP045085A/es unknown
- 2004-04-28 ZA ZA200403184A patent/ZA200403184B/en unknown
- 2004-05-24 NO NO20042133A patent/NO20042133L/no not_active Application Discontinuation
- 2004-05-25 CO CO04048129A patent/CO5580792A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003034938A3 (en) | 2003-11-13 |
EP1441749A4 (en) | 2010-05-19 |
HUP0402036A2 (hu) | 2005-02-28 |
KR20040051618A (ko) | 2004-06-18 |
WO2003034938A2 (en) | 2003-05-01 |
NO20042133L (no) | 2004-07-09 |
MXPA04003906A (es) | 2005-02-17 |
IL161583A0 (en) | 2004-09-27 |
NZ532593A (en) | 2007-11-30 |
ECSP045085A (es) | 2004-07-23 |
CA2464093A1 (en) | 2003-05-01 |
CO5580792A2 (es) | 2005-11-30 |
US20040044405A1 (en) | 2004-03-04 |
CN1635858A (zh) | 2005-07-06 |
EP1441749A2 (en) | 2004-08-04 |
BR0213497A (pt) | 2006-05-23 |
ZA200403184B (en) | 2005-05-12 |
PL374315A1 (en) | 2005-10-03 |
JP2006519623A (ja) | 2006-08-31 |
RU2004116068A (ru) | 2005-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0402036A3 (en) | Vascular stent or graft coated or impregnated with protein tyrosine kinase inhibitors and method of using same | |
AU2001285059A1 (en) | Coated vascular grafts and methods of use | |
PL346604A1 (en) | Coated stent and method of coating same | |
AU2002316254A1 (en) | Prosthetic graft assembly and method of use | |
EP2425800B8 (en) | Implantable intraluminal device and method of using same in treating aneurysms | |
AU2003217329A1 (en) | Coated vascular prosthesis and methods of manufacture and use. | |
AU2002211304A1 (en) | Systems and methods for assessing vascular effects of a treatment | |
AU2003300323A8 (en) | Vascular prosthesis and methods of use | |
AU2002357285A1 (en) | Intravascular stent and method of use | |
HK1060721A1 (en) | Method of making coated articles and coated articles made thereby | |
AU2002233936A1 (en) | Endoluminal stent, self-fupporting endoluminal graft and methods of making same | |
HK1172504A1 (en) | Composition and methods for modulation of vascular structure and or function | |
EP1581147A3 (en) | Vascular prosthesis and methods of use | |
AU2002360512A8 (en) | Stent for treating bifurcations and method of use | |
AU8681798A (en) | Imidazoquinoxaline protein tyrosine kinase inhibitors | |
AU8681698A (en) | Imidazoquinoxaline protein tyrosine kinase inhibitors | |
AU2002213349A1 (en) | Stent and catheter assembly and method for treating bifurcated vessels | |
EP1266570A4 (en) | COATING MATERIALS FOR BIOLOGICAL FABRICS, COATED BIOLOGICAL FABRICS AND METHOD FOR COATING BIOLOGICAL TISSUES | |
AU2396897A (en) | 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick | |
PT1534139T (pt) | Sistema e método de caracterização de tecido vascular | |
AU2001247425A1 (en) | Selectively coated stent delivery system and method of manufacture thereof | |
AU2002356964A1 (en) | Graft and method of making | |
AU2001259198A1 (en) | Stent graft assembly and method | |
AU2876000A (en) | Tyrosine kinase inhibitors and methods of using the same | |
AU1456899A (en) | Human protein kinase and kinase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |